147 related articles for article (PubMed ID: 35594186)
1. Framework Nucleic Acid Immune Adjuvant for Transdermal Delivery Based Chemo-immunotherapy for Malignant Melanoma Treatment.
Shen F; Sun L; Wang L; Peng R; Fan C; Liu Z
Nano Lett; 2022 Jun; 22(11):4509-4518. PubMed ID: 35594186
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy.
Liu M; Hao L; Zhao D; Li J; Lin Y
ACS Appl Mater Interfaces; 2022 Aug; 14(34):38506-38514. PubMed ID: 35973112
[TBL] [Abstract][Full Text] [Related]
4. Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
Najar HM; Dutz JP
J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132
[TBL] [Abstract][Full Text] [Related]
5. Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy.
Kuai R; Sun X; Yuan W; Ochyl LJ; Xu Y; Hassani Najafabadi A; Scheetz L; Yu MZ; Balwani I; Schwendeman A; Moon JJ
J Control Release; 2018 Jul; 282():131-139. PubMed ID: 29702142
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer.
Makkouk A; Joshi VB; Wongrakpanich A; Lemke CD; Gross BP; Salem AK; Weiner GJ
AAPS J; 2015 Jan; 17(1):184-93. PubMed ID: 25331103
[TBL] [Abstract][Full Text] [Related]
7. A dual-adjuvant neoantigen nanovaccine loaded with imiquimod and magnesium enhances anti-tumor immune responses of melanoma.
Chen X; Cen L; Liu Q; Chu Y; Feng X; Ke Y; Zhang Z; Dai H; Huang S; Liu B; Qian X
Biomater Sci; 2022 Nov; 10(23):6740-6748. PubMed ID: 36285738
[TBL] [Abstract][Full Text] [Related]
8. Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.
van den Boorn JG; Konijnenberg D; Tjin EP; Picavet DI; Meeuwenoord NJ; Filippov DV; van der Veen JP; Bos JD; Melief CJ; Luiten RM
PLoS One; 2010 May; 5(5):e10626. PubMed ID: 20498710
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect.
Song X; Jiang Y; Zhang W; Elfawal G; Wang K; Jiang D; Hong H; Wu J; He C; Mo X; Wang H
Acta Biomater; 2022 Mar; 140():247-260. PubMed ID: 34843953
[TBL] [Abstract][Full Text] [Related]
10. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.
Xia C; Yin S; Xu S; Ran G; Deng M; Mei L; Tang X; Rao J; Li M; Zhang Z; He Q
Theranostics; 2019; 9(2):337-354. PubMed ID: 30809278
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma.
Xia Y; Wei J; Zhao S; Guo B; Meng F; Klumperman B; Zhong Z
J Control Release; 2021 Aug; 336():262-273. PubMed ID: 34174350
[TBL] [Abstract][Full Text] [Related]
12. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X
Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy.
Kigasawa K; Kajimoto K; Nakamura T; Hama S; Kanamura K; Harashima H; Kogure K
J Control Release; 2011 Mar; 150(3):256-65. PubMed ID: 21256903
[TBL] [Abstract][Full Text] [Related]
14. A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide.
Jia H; Guo J; Wang P; Sun K; Chen J; Ren W; Wei T; Yang Y; Li J; Liu X; Li R; Zhong J; Wang M; Tian Z; Feng Z; Zhao T
Int Immunopharmacol; 2020 Jun; 83():106397. PubMed ID: 32220805
[TBL] [Abstract][Full Text] [Related]
15. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.
Lu Y; Wang Y; Miao L; Haynes M; Xiang G; Huang L
Cancer Lett; 2016 Aug; 379(1):32-8. PubMed ID: 27235608
[TBL] [Abstract][Full Text] [Related]
16. A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth.
Gleisner MA; Pereda C; Tittarelli A; Navarrete M; Fuentes C; Ávalos I; Tempio F; Araya JP; Becker MI; González FE; López MN; Salazar-Onfray F
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690772
[TBL] [Abstract][Full Text] [Related]
17. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.
Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X
J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903
[TBL] [Abstract][Full Text] [Related]
18. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
19. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
Front Immunol; 2020; 11():583382. PubMed ID: 33240271
[TBL] [Abstract][Full Text] [Related]
20. Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy.
Zhang LX; Xie XX; Liu DQ; Xu ZP; Liu RT
Biomaterials; 2018 Aug; 174():54-66. PubMed ID: 29778982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
